Ambrosia Biosciences Inc. is a privately held drug discovery company focused on developing orally delivered, small‑molecule therapies for obesity and other metabolic disorders. Leveraging expertise in GLP‑1 and incretin hormone pathways, the company targets Class B G protein‑coupled receptors to create highly selective, patient‑friendly treatments. Ambrosia’s pipeline emphasizes rapid absorption and sustained efficacy, positioning it as a leader in oral metabolic therapeutics. The firm’s collaborative culture and commitment to innovation make it an attractive destination for scientists and business professionals seeking to advance next‑generation metabolic care.
Open Positions
Senior / Principal Scientist, DMPK
Ph.D. in DMPK, pharmacokinetics, pharmaceutical sciences, or a related discipline with 2–5 years of experience or M.S. with 5–7 years of experience. Hands-on experience in small-molecule DMPK within biotech or pharmaceutical drug discovery and working knowledge of LC-MS/MS bioanalysis, HPLC systems, and triple quadrupole mass spectrometry